Cargando…

Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors

Detalles Bibliográficos
Autores principales: Song, Peng, Zhang, Jingcheng, Shang, Congcong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985121/
https://www.ncbi.nlm.nih.gov/pubmed/31988322
http://dx.doi.org/10.1038/s41598-020-58487-5
_version_ 1783491753631809536
author Song, Peng
Zhang, Jingcheng
Shang, Congcong
Zhang, Li
author_facet Song, Peng
Zhang, Jingcheng
Shang, Congcong
Zhang, Li
author_sort Song, Peng
collection PubMed
description
format Online
Article
Text
id pubmed-6985121
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69851212020-01-31 Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors Song, Peng Zhang, Jingcheng Shang, Congcong Zhang, Li Sci Rep Author Correction Nature Publishing Group UK 2020-01-27 /pmc/articles/PMC6985121/ /pubmed/31988322 http://dx.doi.org/10.1038/s41598-020-58487-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Author Correction
Song, Peng
Zhang, Jingcheng
Shang, Congcong
Zhang, Li
Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title_full Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title_fullStr Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title_full_unstemmed Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title_short Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
title_sort author correction: real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with pd-1/pd-l1 inhibitors
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985121/
https://www.ncbi.nlm.nih.gov/pubmed/31988322
http://dx.doi.org/10.1038/s41598-020-58487-5
work_keys_str_mv AT songpeng authorcorrectionrealworldevidenceandclinicalobservationsofthetreatmentofadvancednonsmallcelllungcancerwithpd1pdl1inhibitors
AT zhangjingcheng authorcorrectionrealworldevidenceandclinicalobservationsofthetreatmentofadvancednonsmallcelllungcancerwithpd1pdl1inhibitors
AT shangcongcong authorcorrectionrealworldevidenceandclinicalobservationsofthetreatmentofadvancednonsmallcelllungcancerwithpd1pdl1inhibitors
AT zhangli authorcorrectionrealworldevidenceandclinicalobservationsofthetreatmentofadvancednonsmallcelllungcancerwithpd1pdl1inhibitors